Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repetitive Transcranial Magnetic Stimulation for Apathy Clinical Trial (REACT)

NCT05561205 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.

NCT NCT05561205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05561205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repetitive Transcranial Magnetic Stimulation for Apathy Clinical Trial (REACT)
Lead sponsor
Sunnybrook Health Sciences Centre
Phase
Not applicable
Overall status
Recruiting
Start date
February 9, 2023
Completion date
December 1, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, apathy in dementia, dementia, mild behavioural impairment, mild cognitive impairment, neurocognitive disorders